Clinical trial

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

NCT01872598

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Masitinib Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Standard of care Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-01-01

PhasePHASE3

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

MasitinibDRUG

PlaceboDRUG

Standard of careDRUG

Sponsors & collaborators

AB Sciencelead sponsor

Mapped research locations

MadridSpain1 BucharestRomania1 BialystokPoland1 ThessalonikiGreece1 VarnaBulgaria1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01872598 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.